FDA Inspection
Burlington Drug CompanyBurlington Drug Company – FDA Inspection, May 24, 2017
Record Details
This FDA Inspection record concerns Burlington Drug Company, with an inspection on May 24, 2017, issued by the Center for Food Safety and Applied Nutrition, covering food/cosmetics.
View Company Profile
ID · d05f5957-af24-45b1-bb5b-5804e9f73299
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012937
- FDA center
- Foods & Cosmetics
- Project area
- Food Composition, Standards, Labeling and Econ
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 111.453Written procedures - holding
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Burlington Drug Company
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 20, 2023 | Not classified | New England District Office |
Other documents for Burlington Drug Company
- FDA Inspection 1211424 - 2023-07-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.